Herbert Irving Comprehensive Cancer Center
Flash Section

Fight Breast Cancer with Avenue Q!

Monday October 19, 2015 at 11:46 AM

Use the code AQAWARE50 and Avenue Q will donate $5 to CUMC's Breast Cancer Program.

GO PINK Volleyball Match

Monday October 19, 2015 at 11:30 AM

 Please join us next Saturday, October 24th at 2pm for the GO PINK volleyball match.

Immunotherapy: New Hope for Patients with Advanced Lung Cancer

Thursday March 12, 2015 at 10:00 AM

"‘Groundbreaking’ and ‘revolutionary’ often overstate the case, but they truly apply to the impact of the new immunotherapy agents," says HICCC's Dr. Naiyer Rizvi.

Herbert Irving Comprehensive Cancer Center 2015 Gala: May 6, 2015

Friday February 13, 2015 at 11:27 AM

The event will honor Florence and Herbert Irving for their extraordinary generosity to CUMC. 

Clinical Trial for sarcoma drug Yondelis now open to patients with metastatic leiomyosarcoma.

Thursday February 12, 2015 at 11:21 AM

Adult: A Multicenter, Open-Label Single-Arm Study of YONDELIS® (trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment

PBS Series Based on HICCC Member Siddhartha Mukherjee's Book Debuts on March 30th

Tuesday February 10, 2015 at 10:36 AM

 The Ken Burns documentary is based on the Pulitzer Prize-winning book The Emperor of All Maladies.


Bone stem cells shown to regenerate bones and cartilage in adult mice

Thursday January 15, 2015 at 4:23 PM

A stem cell capable of regenerating both bone and cartilage has been identified in bone marrow of mice. The discovery by researchers at Columbia University Medical Center (CUMC) is reported today in the online issue of the journal Cell.

Tracing Cancer Back to Its Origins

Monday January 12, 2015 at 11:27 AM

Some bladder cancers look like tiny fingers. Others look like flat bed sheets.

The differences are obvious and they have clinical implications. The “fingers” of papillary tumors often grow back after surgery, but flat carcinoma in situ cancers are typically more aggressive and more likely to spread.

“The big question is why,” says Cathy Mendelsohn, PhD, a professor of urology, pathology & cell biology, and genetics & development, who has been studying bladder development and regeneration at Columbia. “Because if we understand how cancers arise, and why some lesions invade and others don’t, we may be able to develop more precise techniques for diagnosis and better therapies for treatment.”